Off-label drug use in pediatrics. Literature review

Author:

Badertdinova D. I., ,Zvegintseva A. A.ORCID,Maksimov M. L.ORCID, ,

Abstract

At present, due to the accumulated developments in pharmacology and pharmacotherapy, there is a huge variety of drugs for the effective treatment and prevention of many common diseases. This makes it possible to control and manage many pathological conditions. However, each drug should be comprehensively studied, as well as its systemic action, side effects, toxicity, effect when interacting with other drugs, and especially when it accumulates in the body, must be taken into account. There are groups of patients in which clinical trials of drugs are difficult and limited. These are pregnant women, children, and newborns, especially premature ones. A serious deterrent is both severe economic restrictions and ethical issues, such as the protection of the rights of minors and the negative attitude of society towards clinical trials as «experiments on people».

Publisher

PANORAMA Publishing House

Subject

General Medicine,Applied Mathematics,General Engineering,General Medicine,General Materials Science,General Energy,General Medicine,Information Systems and Management,Information Systems,Software,General Medicine,General Medicine

Reference31 articles.

1. 1. Federal Law of the Russian Federation of April 12, 2010 No. 61-FZ «On the circulation of medicines» adopted by the State Duma on March 24, 2010. Approved by the Federation Council on March 31, 2010. (In Russ.)

2. 2. Federal Law of the Russian Federation of November 21, 2011 No. 323-FZ «On the basics of protecting the health of citizens in the Russian Federation» // Rossiyskaya Gazeta, November 23, 2011 No. 263. (In Russ.)

3. 3. Kuzmin S. B., Smirnova M. N. Problema primeneniia lekarstvennykh sredstv v neonatologii [The problem of the use of drugs in neonatology] // Meditsinskoe pravo: teoriia i praktika [Medical Law: Theory and Practice], No. 1. All-Russian scientific and practical conference with international participation «Formation of legal medicine in Russia». (In Russ.)

4. 4. Tarabukina S. M., Dremova N. B. Problema izgotovleniia v bolnichnoi apteke lekarstvennykh preparatov, naznachaemykh «off-label» [The problem of manufacturing medicines prescribed «off-label» in a hospital pharmacy]. Journal Sovremennaia organizatsiia lekarstvennogo obespecheniia [Modern Organization of Drug Supply]. Volume 8, No. 1, 2021. (In Russ.)

5. 5. Kuznetsova E. Iu., Ovchinnikova P. P., Semencheva A. S. Problema primeneniia lekarstvennykh preparatov «off-label» v Rossii [The problem of off-label drug use in Russia] // Mezhdunarodnyi nauchno-issledovatelskii zhurnal [Scientific International Research Journal], 2020. (In Russ.)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3